Smith & Nephew plc (SNNUF)

Market Cap	13.47B +9.2%
Revenue (ttm)	6.16B +6.1%
Net Income	625.00M +51.7%
EPS	0.72 +52.3%
Shares Out	n/a
PE Ratio	21.56
Forward PE	14.18
Dividend	0.39 (2.44%)
Ex-Dividend Date	Mar 26, 2026

Volume	1,000
Average Volume	1,296
Open	16.05
Previous Close	16.50
Day's Range	16.05 - 16.05
52-Week Range	12.55 - 18.50
Beta	0.68
RSI	46.31
Earnings Date	Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1856
• Employees: 16,988
• Stock Exchange: OTCMKTS
• Ticker Symbol: SNNUF

Financial Performance

In 2025, Smith & Nephew's revenue was $6.16 billion, an increase of 6.09% compared to the previous year's $5.81 billion. Earnings were $625.00 million, an increase of 51.70%.